Purpose: To present clinical results of toric intraocular lens (IOL) implantation for preexisting astigmatism correction and determine the time of any postoperative rotation.
Patients And Methods: Twenty-nine eyes of 19 patients underwent uncomplicated phacoemulsification and were implanted with an Acrysof ((c)) toric IOL. Uncorrected visual acuity, residual astigmatism, and postoperative rotation of the IOL were estimated one and six months after the operation.
Results: Uncorrected visual acuity was >/=0.5 in 26 of 29 eyes (89.7%) and >/=0.8 in 19 of 29 patients (65.5%). The mean toric IOL axis rotation was 2.2 +/- 1.5 degrees (range 0.6-7.8 degrees ) one month postoperation and 2.7 +/- 1.5 degrees (range 0.9-8.4 degrees ) six months postoperation.
Conclusion: Implantation of one-piece hydrophobic acrylic toric IOLs appears to have acceptable stability, which encourages visual outcome and emerges as an attractive alternative for correction of refractive astigmatism.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850825 | PMC |
http://dx.doi.org/10.2147/opth.s9608 | DOI Listing |
Clin Ophthalmol
December 2024
The Department of Ophthalmology, The Shammas Eye Medical Center, Lynwood, CA, USA.
Purpose: To evaluate the clinical outcomes of a new FDA approved toric aspheric hydrophobic acrylic intraocular lens.
Patients And Methods: This is a single surgeon, single-arm, on-label, non-randomized, prospective observational study. Thirty patients underwent bilateral cataract surgery (60 eyes) with placement of a Clareon™ Toric IOL in each eye.
Clin Ophthalmol
November 2024
Sengi, Penniac, NB, Canada.
J Cataract Refract Surg
November 2024
Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
Purpose: To investigate the accuracy of three distinct postoperative toric intraocular lens (TIOL) rotational stability measurement methods.
Setting: Department of Ophthalmology and Optometry, Medical University of Vienna, Austria.
Design: Single-center, prospective, interventional clinical trial.
J Cataract Refract Surg
December 2024
From the Cleveland Eye Clinic, Elyria, Ohio (Wiley); The Eye Center of Columbus, Columbus, Ohio (Epitropoulos); Key-Whitman Eye Center, Dallas, Texas; Center For Sight, Las Vegas, Nevada (Liang); Visionary Eye Institute, Newport Beach, California (Sadri); Bausch & Lomb, Inc., Bridgewater, New Jersey (Lau).
Purpose: To evaluate the rotational stability and visual performance of the enVista toric intraocular lens (IOL) (MX60ET) in cataract patients with preexisting astigmatism.
Setting: 6 U.S.
Eye Vis (Lond)
July 2024
Department of Ophthalmology and Optometry of the Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Purpose: To assess rotational stability and refractive outcomes of a new toric hydrophobic acrylic intraocular lens (IOL).
Design: Single-center, prospective, interventional clinical trial.
Methods: A total of 130 eyes of 82 patients with age-related cataract and total corneal astigmatism of greater than 1.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!